USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANOTRANS TECHNOLOGIES, INC.
Address:
14 E 96TH ST
NEW YORK, NY 10128-0781
Phone:
N/A
URL:
N/A
EIN:
126229332
DUNS:
829871495
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $271,468.00 1

Award List:

Topical Nanoparticles for CNV

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$271,468.00
Agency:
HHS
Principal Investigator:
Uday B. Kompella – 303-724-4028
Research Institution:
University Of Colorado Denver/Hsc Denver
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Age Related Macular Degeneration (AMD) is the leading cause of blindness in adults over 50 years. Choroidal neovascularization (CNV), the pathologic creation of new blood vessels in the choroid layer of the eye, is a principal cause of blindness due to AMD.… More